Objective: The advent of Electronic Medical Records (EMR) with large electronic imaging databases along with advances in deep neural networks with machine learning has provided a unique opportunity to achieve milestones in automated image analysis. Optical coherence tomography (OCT) is the most commonly obtained imaging modality in ophthalmology and represents a dense and rich dataset when combined with labels derived from the EMR. We sought to determine if deep learning could be utilized to distinguish normal OCT images from images from patients with Age-related Macular Degeneration (AMD).
INTRODUCTION
Optical coherence tomography (OCT) has become the most commonly used imaging modality in ophthalmology with 4.39 million, 4.93 million, and 5.35 million OCTs performed in 2012, 2013, and 2014 respectively in the US Medicare population. 1 Since its development in 1991, 2 a 70-fold increase in OCT use for diagnosing age-related macular degeneration (AMD) was reported between 2002 and 2009. 3 Furthermore, since the development of anti-angiogenic agents, OCT has become a critical tool for baseline retinal evaluation prior to initiation of therapy and monitoring therapeutic effect. 4, 5 This increase in the use of OCT imaging, with images stored in large electronic databases, highlights the ever-increasing time and effort spent by providers interpreting images.
The key OCT findings in AMD, including drusen, retinal pigmented epithelium (RPE) changes, and subretinal and intraretinal fluid, 4 share some common OCT features that are distinctively different from a normal retina. 6 Correct identification of these characteristics allows for precise management of neovascular AMD and guides the decision of whether intravitreal therapy with anti-VEGF agents should be given or not. [7] [8] [9] Computer aided diagnosis (CAD) has the potential for allowing more efficient identification of pathological OCT images and directing the attention of the clinician to regions of interest on the OCT images.
The concept of CAD is not novel and has been applied in radiology, a field where the increasing demand of imaging studies has begun to outpace the capacity of practicing radiologists. 10 A number of CAD systems have been approved by the Food and Drug Administration (FDA) for lesion detection and volumetric analysis in mammography, chest radiography, and chest computed tomography.
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Traditional image analysis required the manual development of convolutional matrices applied to an image for edge detection and feature extraction. In addition, prior work on OCT image classification of diseases has relied on machine learning techniques such as Principal
Components Analysis, Support Vector Machine, or Random Forest. [12] [13] [14] However recently, there has been a revolutionary step forward in machine learning techniques with the advent of deep learning where a many-layered neural network is trained to develop these convolutional matrices purely from training data. 15 Specifically, the development of convolutional neural network layers allowed for significant gains in the ability to classify images and detect objects in a picture. [16] [17] [18] Within ophthalmology, deep learning has been recently applied at a limited capacity to automated detection of diabetic retinopathy from fundus photos, visual field perimetry in glaucoma patients, grading of nuclear cataracts, and segmentation of foveal microvasculature, each with promising initial findings. [19] [20] [21] [22] While deep learning has revolutionized the field of computer vision, their application is usually limited due to the lack of large training sets. Often several tens of thousands of examples are required before deep learning can be used effectively. With the ever increasing use of OCT as an imaging modality in ophthalmology along with the use of codified structured clinical data in the Electronic Medical Record (EMR), we sought to link two large datasets together to use as a training set for developing a deep learning algorithm to distinguish AMD from normal OCT images.
METHODS
This study was approved by the Institutional Review Board of the University of Washington (UW) and was in adherence with the tenets of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act.
OCT and EMR Extraction
Macular OCT scan were extracted using an automated extraction tool from the Heidelberg Specifically, all clinical diagnoses and the dates of every clinical encounter, macular laser procedures, and intravitreal injections were extracted from the EPIC Clarity tables.
Patient and Image Selection
A normal patient was defined as having no retinal ICD-9 diagnosis and better than 20/30 vision in both eyes during the entirety of recorded clinical history at UW. An AMD patient was defined as having the ICD-9 diagnosis of AMD (362.50, 362.51, and 362.52) by a retina specialist, at least one intravitreal injection in either eye, and worse than 20/30 vision in the better seeing eye. Patients with other macular pathology by ICD-9 code were excluded. These parameters were chosen a priori to ensure that macular pathology was most likely present in both eyes in the AMD patients and absent in both eyes in the normal patients. Consecutive images of patients meeting this criteria were included and no images were excluded due to image quality. Labels from the EMR were then linked to the OCT macular images, and the data was stripped of all protected health identifiers.
As most of the macular pathology is concentrated in foveal region, the decision was made a priori to select the central 11 images from each macular OCT set, and each image was then treated independently, labeled as either normal or AMD. The images were histogram equalized and the resolution down-sampled to 192x124 due to limitations of memory. The image set was then divided into two sets with 20% of the patients in each group placed into the validation set and the rest were used for training. Care was taken to ensure that the validation set and the training set contained images from mutually exclusive group of patients (i.e. no single patient contributed images to both the training and validation set). The order of images was then randomized in the training set.
Deep Learning Classification Model
A modified version of the VGG16 convolutional neural network 23 was used as the deep learning model for classification ( Figure 1 ). Weights were initialized using the Xavier algorithm. 24 Training was then performed using multiple iterations each with a batch size of 100 images with a starting learning rate of 0.001 with stochastic gradient descent optimization. At each iteration, the loss of the model was recorded, and at every 500 iterations, the performance of the neural network was assessed using cross-validation with the validation set. The training was stopped when the loss of the model decreased and the accuracy of the validation set decreased.
An occlusion test 17 At the level of each individual image, we achieved an accuracy of 87.63% with a sensitivity of 84.63% and a specificity of 91.54%. After constructing an ROC curve, the peak sensitivity and specificity with optimal cutoffs were 87.08% and 87.05% respectively. The area under the ROC curve (AUROC) was 92.77%.
By grouping the images in the same OCT scan and averaging the probabilities from each image, we achieved an accuracy of 88.98% with a sensitivity of 85.41% and a specificity of 93.82%. After constructing the ROC curve, the peak sensitivity and specificity with optimal cutoffs were 88.63% and 87.77%. The AUROC was 93.82%.
By averaging the probabilities from each image from the same patient, we achieved an accuracy of 93.45% with a sensitivity of 83.82% and a specificity of 96.40%. After constructing the ROC curve, the peak sensitivity and specificity with optimal cutoffs were 92.64% and 93.69%. The AUROC was 97.46%.
Example images from the occlusion test are shown in Figure 4 showing that the neural network was successfully able to identify pathological regions on the OCT. These areas represent the most critical area in each image to the trained network in categorizing the image as AMD.
DISCUSSION
The ever increasing use of digital imaging and EMRs provide opportunities to create deep and rich datasets for analysis. Our study demonstrates that a deep learning neural network was effective at distinguishing AMD from normal OCT images, and its accuracy was even higher when aggregate probabilities at the OCT macular scan and patient level were combined. The increase in the AUROC mainly occurred with an increase in the sensitivity (Figure 3 Only limited applications of deep learning models exist in ophthalmology. Abramoff et al.
reported sensitivity of 96.8% and specificity of 87.0% in detecting referable diabetic retinopathy in 874 patients using deep learning model, but no details of the algorithm were included. 20 Asaoka et al. used a deep learning method to differentiate the visual fields of 27 patients with preperimetric open angle glaucoma from 65 controls. 19 The AUROC of 92.6% was achieved with this study's feed-forward network classifier, but the algorithm only used four layers of neurons. In contrast, our study deep learning algorithm included 21 layers of neurons with state of the art convolutional neural networking layers. Other smaller studies that have applied automated OCT classification algorithms did not integrate deep learning strategies and was limited by small sample size ranging from 32 to 384. 12, 19, 20 Our deep learning algorithm is a novel application to OCT classification in ophthalmology. To our best knowledge, the use of training and validation images from large EMR extraction has never been shown. In order to verify how the deep learning algorithm categorized the images as AMD, we performed an occlusion test where we systematically occluded every location in the image with a blank 20x20 pixel area. The deep learning neural network successfully identified key areas of interest on the OCT image, which corresponded to the areas of pathology ( Figure   4 ).
The application of occlusion testing provides insight into the trained deep learning model and which features were most important in distinguishing AMD images from normal images. In Figure 4C , occlusion testing did not show high intensity dependence in the area of nasal high choroidal transmission suggesting that the classifier was not using this as an important feature.
One possible explanation is that in distinguishing normal from AMD OCT images, the classifier already achieved very low loss ( Figure 2B ) using the identified features and never discovered further improvements. Further studies could be performed where a classifier is specifically trained to distinguish specific AMD OCT features such as drusen, subretinal fluid, pigment epithelial detachments, and high choroidal transmission from each other.
Our study findings have several limitations. We only included images from patients who met our study criteria and the neural network was only trained on these images. However, we included consecutive real-world images and did not exclude images with poor quality. In addition, the training of this model was only done on images from a single academic center and the external generalizability is unknown. Future studies would include expanding the number of diagnoses, using all images from a macular OCT scan, including images from different OCT manufacturers, and validation on OCT scans from other institutions.
In the future, our approach may be used to develop deep learning models that can have a number of wide-reaching applications. First, the models can be applied to various retinal or choroidal pathologies in which OCT evaluations are essential, including diabetic retinopathy or retinal vein occlusions. Second, in future studies using deep learning, automated macular OCT classification could be used as a screening tool for retinal pathology when the hardware cost of OCT machines decreases. This automated classification could be added to the majority of OCT machines being used in clinical practice without the need of integrating GPU as the inference step of deep learning is computationally inexpensive compared to training and can be run on standard computers. The automated classification feature will likely be beneficial in a large screening model such as in an AMD screening system. Finally, deep learning models can identify concerning macular OCT images and efficiently display them to the clinician to aid in the diagnosis and treatment of macular pathology, much like computer-aided diagnosis models found in radiology.
In conclusion, we demonstrate the ability of a deep learning model to distinguish AMD versus normal OCT images and show encouraging results for the first application of deep learning to OCT images. Future follow up studies will include widening the number of diseases and showing external validity of the model using images from other institutions. Each iteration represents 100 images being trained on the neural network. 
